Evidence map›Paper›PMID 39108007›Full record

ReviewCurrent topics in medicinal chemistry2024

Recent Advances in the Synthesis of Antioxidant Derivatives: Pharmacological Insights for Neurological Disorders.

Kuldeep Singh, Jeetendra Kumar Gupta, Pranshul Sethi, Sojomon Mathew, Alok Bhatt, Mukesh Chandra Sharma, Sunam Saha, Shamim, Shivendra Kumar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current topics in medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Serotonergic Regulation in Alzheimer's Disease.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kuldeep SinghDepartment of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura Uttar Pradesh, India.ORCID 0000-0001-8772-8157
Jeetendra Kumar GuptaDepartment of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura Uttar Pradesh, India.ORCID 0000-0002-5819-371X
Pranshul SethiDepartment of Pharmacology, College of Pharmacy, Shri Venkateshwara University, Gajraula, Uttar Pradesh, India.ORCID 0000-0002-8684-9683
Sojomon MathewDepartment of Zoology, Government College, Kottayam, Kerala, India.ORCID 0000-0002-4442-9875
Alok BhattSchool of Pharmacy, Graphic Era Hill University, Bell Road, Clement Town, Dehradun, Uttarakhand, India.ORCID 0000-0001-8680-7339
Mukesh Chandra SharmaSchool of Pharmacy, Devi Ahilya Vishwavidalaya, Indore, (M.P.), India.ORCID 0000-0003-0222-5273
Sunam SahaDepartment of Chemistry, Institute of Pharmaceutical Research, GLA University, Mathura Uttar Pradesh, India.ORCID 0000-0003-1911-940X
ShamimIIMT College of Medical Sciences, IIMT University, Meerut, Uttar Pradesh, India.ORCID 0009-0005-6103-1243
Shivendra KumarDepartment of Pharmacology, Rajiv Academy for Pharmacy, Mathura, Uttar Pradesh, India.ORCID 0000-0002-2287-6981

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurological disorders, characterized by oxidative stress (OS) and inflammation, have become a major global health concern. Redox reactions play a vital role in regulating the balance of the neuronal microenvironment. Specifically, the imbalance leads to a significant weakening of the organism's natural defensive mechanisms. This, in turn, causes the development of harmful oxidative stress, which plays a crucial role in the onset and progression of neurodegenerative diseases. The quest for effective therapeutic agents has led to significant advancements in the synthesis of antioxidant derivatives. This review provides a comprehensive overview of the recent developments in the use of novel antioxidant compounds with potential pharmacological applications in the management of neurological disorders. The discussed compounds encompass a diverse range of chemical structures, including polyphenols, vitamins, flavonoids, and hybrid molecules, highlighting their varied mechanisms of action. This review also focuses on the mechanism of oxidative stress in developing neurodegenerative disease. The neuroprotective effects of these antioxidant derivatives are explored in the context of specific neurological disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. The ultimate goal is to provide effective treatments for these debilitating conditions and improve the quality of life for patients.

Indexed as

AntioxidantsOxidative StressAnimalsHumansNervous System DiseasesNeurodegenerative DiseasesNeuroprotective AgentsAntioxidantsNeuroprotective AgentsAlzheimer's diseaseAntioxidant derivativesDrug developmentFlavonoidsNeuroinflammationNeurological disordersNeuroprotectionOxidative stressParkinson's disease.Polyphenols

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.